Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $939.74 | 35 | 50.8% |
| Long term medical supply or device loan | $911.92 | 1 | 49.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec USA, Inc. | $911.92 | 1 | $0 (2022) |
| TISSUETECH, INC. | $352.50 | 9 | $0 (2021) |
| Allergan, Inc. | $148.21 | 7 | $0 (2020) |
| ABBVIE INC. | $128.59 | 4 | $0 (2023) |
| Genentech USA, Inc. | $70.40 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $65.22 | 3 | $0 (2019) |
| Shire North American Group Inc | $35.16 | 2 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $34.86 | 2 | $0 (2020) |
| BioTissue Holdings, Inc. | $29.52 | 1 | $0 (2022) |
| Amgen Inc. | $25.06 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.06 | 1 | Amgen Inc. ($25.06) |
| 2023 | $104.30 | 3 | ABBVIE INC. ($104.30) |
| 2022 | $965.73 | 3 | Carl Zeiss Meditec USA, Inc. ($911.92) |
| 2021 | $58.61 | 2 | TISSUETECH, INC. ($43.85) |
| 2020 | $117.26 | 6 | Allergan, Inc. ($64.66) |
| 2019 | $299.05 | 10 | TissueTech, Inc. ($153.78) |
| 2018 | $102.59 | 4 | TissueTech, Inc. ($63.80) |
| 2017 | $179.06 | 7 | TissueTech, Inc. ($69.64) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/14/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: EYE CARE | ||||||
| 08/25/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: EYE CARE | ||||||
| 03/27/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: EYE CARE | ||||||
| 07/13/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 06/30/2022 | Carl Zeiss Meditec USA, Inc. | CLARUS (Device) | Long term medical supply or device loan | In-kind items and services | $911.92 | General |
| Category: Fundus Camera | ||||||
| 06/16/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: GLAUCOMA | ||||||
| 08/06/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $43.85 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 07/22/2021 | Sight Sciences, Inc. | TearCare SmartLid (Device), TEARCARE(TM) (2.2) SYSTEM KIT | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Ophthalmology | ||||||
| 11/30/2020 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Medical Device (510K) | ||||||
| 11/18/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: GLAUCOMA | ||||||
| 11/09/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Glaucoma | ||||||
| 08/06/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: GLAUCOMA | ||||||
| 05/31/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: GLAUCOMA | ||||||
| 03/11/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Ophthalmology | ||||||
| 12/04/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: OCULAR | ||||||
| 08/10/2019 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $78.95 | General |
| Category: Medical Device (510K) | ||||||
| 06/12/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Ophthalmology | ||||||
| 06/07/2019 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $29.39 | General |
| Category: Medical Device (510K) | ||||||
| 05/20/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/22/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/13/2019 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $45.44 | General |
| Category: Medical Device (510K) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 154 | 159 | $28,590 | $10,606 |
| 2021 | 10 | 527 | 583 | $102,560 | $49,369 |
| 2020 | 14 | 505 | 580 | $79,970 | $25,688 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2022 | 40 | 40 | $8,000 | $3,783 | 47.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 41 | 46 | $5,750 | $2,945 | 51.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 13 | 13 | $2,925 | $1,461 | 49.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 31 | 31 | $7,130 | $1,433 | 20.1% |
| 92250 | Photography of the retina | Office | 2022 | 29 | 29 | $4,785 | $983.71 | 20.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 194 | 199 | $39,800 | $23,509 | 59.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 77 | 105 | $13,125 | $9,353 | 71.3% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 82 | 87 | $20,010 | $5,344 | 26.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 22 | 22 | $4,950 | $3,009 | 60.8% |
| 92250 | Photography of the retina | Office | 2021 | 63 | 65 | $10,725 | $2,356 | 22.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 27 | 34 | $4,250 | $1,348 | 31.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 20 | $2,300 | $1,339 | 58.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $1,925 | $1,196 | 62.2% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 15 | 19 | $2,850 | $1,192 | 41.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 21 | 21 | $2,625 | $722.22 | 27.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 97 | 112 | $14,000 | $4,751 | 33.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 64 | 64 | $12,800 | $4,313 | 33.7% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 72 | 96 | $17,780 | $3,930 | 22.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 38 | $4,370 | $2,700 | 61.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 34 | 38 | $2,850 | $1,621 | 56.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 19 | $2,185 | $1,385 | 63.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 35 | 46 | $4,455 | $1,140 | 25.6% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2020 | 25 | 25 | $3,690 | $1,134 | 30.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 22 | 25 | $1,875 | $1,084 | 57.8% |
| 92250 | Photography of the retina | Office | 2020 | 28 | 33 | $4,620 | $1,063 | 23.0% |
About Dr. August Reader, MD
Dr. August Reader, MD is a Ophthalmology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053312157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. August Reader, MD has received a total of $1,852 in payments from pharmaceutical and medical device companies, with $25.06 received in 2024. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($939.74).
As a Medicare-enrolled provider, Reader has provided services to 1,186 Medicare beneficiaries, totaling 1,322 services with total Medicare billing of $85,663. Data is available for 3 years (2020–2022), covering 29 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location San Francisco, CA
- Active Since 08/10/2005
- Last Updated 07/13/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1053312157
Products in Payments
- CLARUS (Device) $911.92
- Prokera (Device) $308.65
- DURYSTA (Drug) $193.25
- PROKERA (Device) $73.37
- Lucentis (Biological) $70.40
- EYLEA AFLIBERCEPT INJECTION (Biological) $45.38
- LUMIGAN (Drug) $37.35
- XIIDRA (Drug) $35.16
- VYZULTA (Drug) $34.86
- TEPEZZA (Biological) $25.06
- RESTASIS (Drug) $21.41
- EYLEA (Biological) $19.84
- INVELTYS (Drug) $18.05
- rocklatan (Drug) $17.41
- TearCare SmartLid (Device) $14.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Francisco
Dr. Daniel Schwartz, M.d, M.D
Ophthalmology — Payments: $8.0M
Shan Lin, Md, MD
Ophthalmology — Payments: $437,860
Dr. Eugene De Juan, Md, MD
Ophthalmology — Payments: $349,911
Dr. H Tanaka, Md, MD
Ophthalmology — Payments: $326,711
Dr. Jay Stewart, Md, MD
Ophthalmology — Payments: $295,001
Dr. Scott So, M.d, M.D
Ophthalmology — Payments: $172,800